Join moderator Lance Burrell and guests Mike Pintek, President, Nuclear & Precision Health Solutions (NPHS) and Dr. Ramji Rajendran, Radiation Oncologist, UroPartners, LLC, Medical Director of Theranostics and Radiation Oncologist with The Specialty Alliance as they speak about Alpha Therapy. 

This podcast is sponsored by Cardinal Health, a Value Initiative member. 

Disclaimer: The clinical views and opinions expressed in this presentation are those of the speakers and are based on their personal clinical experience. It should not be considered medical guidance. Any mention of a specific product is for illustration purposes.

Any verbal evaluations and opinions expressed by clinicians are independent and not approved by Cardinal Health.

This discussion addresses early-stage research, isotope supply, and operational considerations. Actinium-225-related applications discussed here are investigational unless and until specifically approved in product labeling. No statement should be interpreted as a recommendation regarding safety, effectiveness, patient selection, or standard-of-care use.

Health care providers are responsible for all medical decisions regarding the use of any drug products with their patients.

Want more SNMMI content? Follow us on:

YouTube | Instagram | LinkedIn | Twitter/X